| |
| |
|
| Insider
Information: |
Murphy Sean |
| Relationship: |
|
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
60,788 |
|
|
Indirect Shares
|
9,713,392 |
|
|
| Direct
Value |
$28,700 |
|
|
|
Indirect Value
|
$26,369,919 |
|
|
| Total
Shares |
9,774,180 |
|
|
| Total
Value |
$26,398,619 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -24.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novan, Inc. |
NOVN |
|
|
0 |
|
0 |
Premium* |
|
|
Poseida Therapeutics, Inc. |
PSTX |
Director, 10% Owner |
2020-07-14 |
10,000 |
2020-07-14 |
9,188,125 |
Premium* |
|
|
Radius Health Inc. |
RDUS |
Director |
2022-08-15 |
0 |
2021-02-22 |
0 |
Premium* |
|
|
Trisalus Life Sciences Ord Shs |
TLSI |
|
2024-02-12 |
50,788 |
2024-02-12 |
525,267 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TLSI |
Trisalus Life Sciences Or... |
CHIEF FINANCIAL OFFICER |
• • – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
34,144 |
50,788 |
0 |
- |
|
| TLSI |
Trisalus Life Sciences Or... |
Chief Financial OfficerOfficer |
• • – |
2023-08-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
525,267 |
|
- |
|
| RDUS |
Radius Health Inc. |
Director |
– • – |
2022-08-15 |
4 |
D |
$10.00 |
$55,000 |
D/D |
(5,500) |
0 |
0 |
- |
|
| RDUS |
Radius Health Inc. |
Director |
– • – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
11,000 |
0 |
- |
|
| RDUS |
Radius Health Inc. |
Director |
– • – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
5,500 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Director |
– • • |
2020-07-14 |
4 |
A |
$0.00 |
$0 |
I/I |
9,188,125 |
9,188,125 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
Director |
– • • |
2020-07-14 |
4 |
B |
$16.00 |
$160,000 |
D/D |
10,000 |
10,000 |
3.92 |
% |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
